About
Mykor grows high-performance, cost-competitive, bio-based building materials.
Grown to perform. Built to scale.
Mykor exists to transform how the world manufactures and builds. We believe the built environment should be able to meet evolving environmental demands without compromising on cost, performance or scalability.
By combining biotechnology, green chemistry and automated manufacturing, we develop the next generation of low-carbon construction products, from prefabricated wall systems to cavity wall insulation.
Our In-House Production
5,000m²
purpose built manufacturing facility
10,000m²
annual production capacity of GROW™ products; POP™ coming soon
2M m²
Target production for our European FOAK (first-of-a-kind) industrial production by 2029
Company Timeline
2022-23
Innovate UK grant secured
and Pre-Seed funding £2M
- First hires joined the team
- Bristol laboratory established
- Core biotechnology platform developed
2024-25
Seed funding and
grant funding £2M
- Pilot factory established in Portugal
- Products independently tested and certified
- EU technical approvals and performance validation
- Commercial pilot production commenced
2026
Pre-Series A funding
and grants £4M
- Engineering blueprint completed for first-of-a-kind (FOAK) manufacturing facility
- Commercial demonstration projects delivered
- Preparation for industrial-scale deployment
Future of Mykor
-
2028
FOAK Constructed
-
2029
2 M m² of MykoSIP annual production
-
2030
10,000 buildings using Mykor products
*20,000 Tonnes of carbon stored; equivalent to the annual electricity consumption of 35,000 homes
Our accreditations
The development and certification of Mykor’s technologies has been made possible through the support of our R&D partners, and recognised by awards including:
